Company Filing History:
Years Active: 2019-2021
Title: Gu Danling - Innovator in Tumor Immunity
Introduction
Gu Danling is a prominent inventor based in San Jose, California. He has made significant contributions to the field of tumor immunity, holding two patents that focus on innovative methods for treating proliferative disorders. His work is vital in advancing cancer treatment methodologies.
Latest Patents
Gu Danling's latest patents revolve around the modulation of tumor immunity. These patents describe methods of treating proliferative disorders, particularly through combination treatments involving a GITR agonist and a PD-1 antagonist. This innovative approach aims to enhance the immune response against tumors, providing new avenues for cancer therapy.
Career Highlights
Gu Danling is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research in immunotherapy.
Collaborations
One of his notable coworkers is Amy M Beebe, with whom he collaborates on various projects related to tumor immunity and cancer treatment.
Conclusion
Gu Danling's work in the field of tumor immunity exemplifies the innovative spirit of modern science. His contributions are paving the way for more effective cancer treatments, showcasing the importance of research and collaboration in the medical field.